Massive Bio, a leader in AI-powered cancer clinical trial enrollment, has published the second issue of Massive Bio magazine. The publication, which had a successful debut in August, features a variety of content for cancer patients and their families, clinicians, and the business community. Featured content in the second issue includes updates on Massive Bio, the latest oncology therapies, cancer and lifestyle, and technology in cancer treatment, as well as stories about cancer patients and their caregivers and advocates.

Click to read our magazine